Exclusive Microbiota Strain
*CFU: Colony Forming Units
CBM588® is a registered mark of Miyarisan.
Food supplement
Teoliance® CBM588® is a dietary supplement formulated with an exclusive probiotic strain: Clostridium butyricum CBM588®. Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer health benefits to the host. They target issues related to digestive health and the gut microbiota, two essential components of overall well-being. Disruptions in the gut microbiota, also known as dysbiosis, can be associated with various conditions, ranging from Irritable Bowel Syndrome (IBS) and increased intestinal permeability (leaky gut) to Inflammatory Bowel Diseases (IBD). Such imbalances can lead to inflammation and weakening of the intestinal barrier.
Some probiotics ensure intestinal well-being and optimal balance through an indirect but fundamental role in the production of short-chain fatty acids (SCFAs), such as butyrate. These SCFAs are naturally produced by gut bacteria during digestion, particularly through the fermentation of dietary fibers. Butyrate's benefits extend beyond its local role in the gut: it is crucial for strengthening intestinal barrier integrity, reducing inflammatory responses, and regulating interactions between the microbiota and the immune system. Probiotics support this production by rebalancing microbiota composition, fostering an environment conducive to the activity of beneficial bacteria that efficiently metabolize dietary fibers.
Thus, the use of Teoliance® CBM588® represents an approach to preserve health and prevent imbalances that could affect overall well-being.
TEOLIANCE® CBM588® is the result of an exclusive partnership with the Japanese laboratory that owns the strain. This partnership guarantees market exclusivity in France, with a precise dosage of 1.35 million CFU* per 3 tablets. This specific and unique strain, derived from decades of rigorous scientific research, has been developed in compliance with the highest quality and safety standards, fitting seamlessly into your daily routine.
*CFU : Colony-Forming Units
Clostridium butyricum CBM588® has been extensively studied, and its biological mechanism of action is well-documented in scientific literature. Numerous studies highlight its promising potential applications in health. However, to date, no health claims have been approved under European legislation.
Despite the lack of official recognition of specific benefits, this growing interest underscores promising perspectives that merit further exploration.
Scientifically selected strain
Clostridium butyricum CBM588® a was chosen based on rigorous scientific studies demonstrating its effectiveness and unique properties. Discovered in Japan in 1933 by Dr. Miyairi, this strain has been the focus of research for decades. Clinical studies have validated its safe use, and its precise characteristics make CBM588® a reliable and effective solution for improving digestive health.
Optimal dosage
The optimal dosage of Clostridium butyricum CBM588® has been carefully selected to ensure both the efficacy and safety of the strain. Clinical studies established the necessary amount to deliver significant benefits while ensuring excellent tolerance. This guarantees that Teoliance® CBM588® provides optimal effects to meet all expectations.
Resistance to gastric acid, temperature, and antibiotics
Clostridium butyricum CBM588® is a Gram-positive bacterium capable of producing spores, which grants it intrinsic resistance to stomach acid conditions, as confirmed by multiple studies. This property ensures the strain's protection and viability until it reaches its action site in the gut, where it can fully exert its benefits.
Guaranteed stability
The stability of Teoliance® CBM588® has been optimized through several key measures. The product is packaged in an opaque glass bottle designed to protect its contents from light and moisture. This opacity ensures the preservation of the strain’s properties throughout its shelf life. Additionally, the strain’s stability is certified for three years, validated by in-depth studies under normal conditions, providing consistent safety and efficacy until its expiration date.
Efficacy and safety
The Novel Food status, defined by European regulations, applies to foods or ingredients not significantly consumed within the European Union before May 15, 1997. To obtain this status, a product undergoes rigorous safety evaluation by the European Food Safety Authority (EFSA), including analyses of its composition, mechanism of action, safety, and absence of health risks.
Clostridium butyricum CBM588® has achieved Novel Food status, allowing its commercialization in Europe, supported by a scientific dossier demonstrating its non-pathogenicity and safety as a probiotic strain. Toxicological and clinical studies confirm its safety, even at high doses. This status ensures the product complies with the highest European standards
1 to 3 tablets per day.
Directions for use:
Food supplements should be used as part of a healthy lifestyle and should not be used as a substitute for a varied and balanced diet. Do not exceed the recommended daily doses. Keep the product out of reach of young children.
If taking multiple dietary supplements, consult your healthcare professional.
After receipt, store the product in a cool dry place.
Lactose (milk), corn starch, Clostridium butyricum (CBM588®), bulking agent: cellulose, sucrose, anti-caking agents: magnesium salts of fatty acids, talc.
| For 3 tablets | |
| Clostridium butyricum CBM588® | 1,35 millions CFU* |
*CFU : Colony Forming Units
Back to school: boost your immune defences and those of your loved ones!
